Trial site
Mount SInai Medical Center
- 29running trials
- 20closed trials
The trials here
What the 52 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma12 trials
- Atrial fibrillation4 trials
- Childhood cancers4 trials
- Acute lymphoblastic leukaemia3 trials
- Acute myeloid leukaemia3 trials
- Coronary artery disease3 trials
- Haemophilia3 trials
- Myelodysplastic syndromes3 trials
- Peripheral artery disease3 trials
- Stroke3 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Hodgkin lymphoma2 trials
- and 22 more
- Phase
- Phase 314 trials
- Phase 212 trials
- Phase 1/25 trials
- Phase 14 trials
- Phase 43 trials
- Status
- Active, not recruiting16 trials
- Completed16 trials
- Recruiting11 trials
- Terminated4 trials
- Suspended3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Boston Scientific Corporation8 trials
- Janssen Research & Development, LLC6 trials
- Hoffmann-La Roche3 trials
- Alliance for Clinical Trials in Oncology2 trials
- Baxalta now part of Shire2 trials
- and 29 more
Running trials
Recruiting
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
Recruiting
Recruiting
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Recruiting
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Recruiting
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Active, not recruiting
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Enrolling by invitation
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease3 recruiting
- Multiple myeloma2 recruiting
- Amyloidosis1 recruiting
- Childhood cancers1 recruiting
- Heart failure1 recruiting
- Liver and biliary tract cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple sclerosis1 recruiting
- Neuroendocrine tumours1 recruiting
- Peripheral artery disease1 recruiting
- Sickle cell disease1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures
Completed
Terminated
STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS
Completed
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
Completed
Completed
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
Completed
Terminated
Completed
Completed
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia
Completed
Terminated
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation
Completed
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Completed
Completed
Completed
Clinical Study of the Treovance Stent-Graft for Patients With Abdominal Aortic Aneurysms
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026